Skip to Content
Merck
HomeApplicationsPharmaceutical & Biopharmaceutical ManufacturingVaccine ManufacturingmRNA Vaccines and Therapeutics Manufacturing

mRNA Vaccines and Therapeutics Manufacturing

Advancing mRNA vaccines and mRNA therapeutics manufacturing together

Advancing mRNA vaccines and mRNA therapeutics manufacturing together

The ability to deliver mRNA molecules into the cytosol of a patient cell offers possibilities for a new class of therapeutics to meet patient needs. The power of these versatile molecules to stimulate patient immune responses was clearly demonstrated with the success of COVID-19 vaccines.

Development of mRNA products is relatively straightforward and offers the possibility of rapid, scalable manufacturing using available technologies. The simplified manufacturing workflow through an enzymatic process minimizes the need for extensive process optimization and enables GMP facilities to quickly switch to new target mRNA products.

Featured Categories

Single-Use Mixers

Explore Mobius® single-use mixing solutions for pharmaceutical ingredient blending and process solution preparation.

Shop Products
Four containers are depicted in the image related to buffers and pH adjusters. The two smaller containers on the left have a red lid and white body. The two larger containers on the right are blue with red-rimmed lids.
Buffers & pH Adjusters

Elevate drug formulation: Explore our GMP-compliant buffer materials tailored for both small and large molecule drugs. Regulatory support included.

Shop Products
Mobius TFF 80 System, Single-use Tangential Flow Filtration Solution, Designed for Large Scale Processing
Tangential Flow Filtration Holders & Systems

Enhance filtration with our advanced tangential flow systems. Minimized hold-up, high concentration, and impeccable recovery for varied applications.

Shop Products
Injectables & Parenteral Formulations

Find high-quality, pure, and reliable raw material solutions to meet your parenteral formulation requirements.

Shop Products
Featured Articles
Manufacturing Strategies for mRNA Vaccines and Therapeutics
mRNA technology uses non-viral delivery systems and offers a great deal of versatility. Delivery of an mRNA into the cytosol of a cell can induce the production of a target protein which can function as a therapeutic or prophylactic, act as an antigen to trigger an immune response for vaccination purposes, replace a defective protein or activate an anti-tumor response.
mRNA Synthesis for the Development of Vaccines and Therapeutics
Understand how mRNA vaccines induce immunity. and read how synthetic mRNA is prepared for vaccine immunogens and other biopharmaceuticals. Find reagents for synthesis of mRNA.
Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?